Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2691387 Title: PROCÉDÉ POUR LA PRÉPARATION DE LA FORME CRISTALLINE II D'ARIPIPRAZOLE ANHYDRE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
127633550
WO application number:
KR2012002349
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
2691387
WO publication number:
WO2012134206
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
30/03/2012
Grant date:
16/12/2015
EP publication date:
05/02/2014
WO publication date:
04/10/2012
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
16/12/2015
EP B1 publication date:
16/12/2015
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
30/03/2032

Applicant

Name:
Daewoong Pharmaceutical Co., Ltd.
Legal Form:
From:
16/12/2015
Address:
244 Galmachi-ro Sangdaewon-dong Jungwon-gu, Seongnam-si, Gyeonggi-do 462-120, Korea (Republic) (KR)
To:

Inventor

1

Name:
CHOI, Soo Jin
Legal Form:
Address:
Yongin-si, Gyeonggi-do 446-918, Korea (Republic) (KR)

2

Name:
OH, Seong Soo
Legal Form:
Address:
Yongin-si, Gyeonggi-do 448-542, Korea (Republic) (KR)

3

Name:
JIN, Yong Suk
Legal Form:
Address:
Ansan-si, Gyeonggi-do 426-855, Korea (Republic) (KR)

4

Name:
KIM, Yong Tae
Legal Form:
Address:
Daejeon 306-060, Korea (Republic) (KR)

5

Name:
LEE, Seung Jae
Legal Form:
Address:
Daejeon 300-817, Korea (Republic) (KR)

6

Name:
SON, Jeong Hyun
Legal Form:
Address:
Suwon-si, Gyeonggi-do 441-440, Korea (Republic) (KR)

Priority

Priority patent number:
20110029931
Priority date:
31/03/2011
Priority country:
Korea (Republic) (KR)

Classification

IPC or IDT classification:
C07D 401/12; A61K 31/496; A61K 31/4709; A61P 25/00; C07D 215/227;

Publication

European Patent Bulletin

Issue number:
201551
Publication date:
16/12/2015
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
30/09/2016
Annual fee number:
5
Annual fee amount:
75 Euro
Penalty fee amount:
85 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type